In the validation group, the ROC curves demonstrated that these genes, MRAP2, PPP1R14A, and PLN, had a high predictive capacity for AAA, as shown by AUC values above 85% (Figures 6E–G), indicating strong diagnostic ability. This evidence concerns the gene MRAP2 and triple-A syndrome.